Myocarditis following<scp>COVID</scp>‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases-Reference-Cited by-同舟云学术

Myocarditis followingCOVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

Published:2022-10-06 Issue:11 Volume:24 Page:2000-2018
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Heidecker Bettina¹^ORCID,Dagan Noa²,Balicer Ran²,Eriksson Urs³,Rosano Giuseppe⁴,Coats Andrew⁵⁶,Tschöpe Carsten⁷,Kelle Sebastian⁷,Poland Gregory A.⁸,Frustaci Andrea⁹¹⁰,Klingel Karin¹¹,Martin Pilar¹²,Hare Joshua M.¹³,Cooper Leslie T.¹⁴,Pantazis Antonis¹⁵,Imazio Massimo¹⁶,Prasad Sanjay¹⁵,Lüscher Thomas F.¹⁵¹⁷^ORCID

Affiliation:

1. Cardiology, Campus Benjamin Franklin, Charité ‐ Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin und Humboldt Universität zu Berlin Berlin Germany

2. Clalit Health Services Clalit Research Institute Ramat Gan Israel

3. Department of Internal Medicine, Division of Cardiology, GZO ‐ Zurich Regional Health Center Wetzikon & University of Zurich Zurich Switzerland

4. St. Georges Medical University of London London UK

5. Monash University Melbourne Victoria Australia

6. University of Warwick Warwick UK

7. Cardiology, German Heart Center Charité – University Medicine Berlin Germany

8. Mayo Clinic Rochester MN USA

9. Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences La Sapienza University Rome Italy

10. IRCCS L. Spallanzani Rome Italy

11. Cardiopathology, Institute for Pathology and Neuropathology University Hospital Tübingen Tübingen Germany

12. Cientro Nacional de Investigationes Cardiovasculares Madrid Spain

13. Interdisciplinary Stem Cell Institute University of Miami Miami FL USA

14. Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA, and Cardiology Mayo Clinic Jacksonville Jacksonville FL USA

15. Royal Brompton and Harefield Hospitals and Imperial College London London UK

16. Cardiothoracic Department, Cardiology Udine University Health Integrated Agency Udine Italy

17. Center for Molecular Cardiology University of Zurich Zurich Switzerland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2669

Reference107 articles.

1. Johns Hopkins Corona Virus Resource Center. COVID‐19 Dashboard.https://coronavirus.jhu.edu/map.html(last accessed 8 September 2022).

2. Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines

3. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

4. Myocarditis following COVID-19 vaccination: magnetic resonance imaging study

5. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safeguarding COVID-19 Vaccines: Establishing the Safety of Novel Vaccine Platforms;Clinical Microbiology and Infection;2024-02

2. What Impact Does the COVID-19 Pandemic Era Have On the Incidence of Myocardial Infarction-Related Fatalities in Distinct Age Groups of Male and Female? A Comparison Study (2017-2022);2024-01-08

3. Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines;Vaccines;2024-01-06

4. Clinical course and follow-up of pediatric patients with COVID-19 vaccine-associated myocarditis compared to non–vaccine-associated myocarditis within the prospective multicenter registry—“MYKKE”;American Heart Journal;2024-01

5. Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study;Vaccine;2024-01